StockDuty ← Dashboard Sep 01, 2026 07:42 AM ET
CatalystFDA/Bio

GSK to advance mRNA seasonal flu vaccine to phase 3 trial

Phase 3 advancement signals key clinical milestone for mRNA flu vaccine.

Phase 3 advancement signals key clinical milestone for mRNA flu vaccine.
Sources